Product Information
TCN-213 is a novel agent that has been shown to inhibit glutamate release from neurons. TCN-213 reduces the amount of glutamate in the synaptic cleft, which may prevent excitotoxicity and subsequent cell death. TCN-213 has been shown to have potent anti-depressant effects in animal models, and it binds to the receptor of the a-type subunit of the N-methyl-D-aspartate (NMDA) class of glutamate receptors. This binding prevents the NMDA receptor from opening, thereby preventing membrane depolarization and neurotransmitter release. The binding affinity for this drug is surmountable, meaning that it can be overcome by high concentrations of glutamate or NMDA. TCN-213 also has a slow off rate, which means that it will stay bound for longer periods of time than other drugs.
Chemical properties
Technical inquiry about: 3D-GXA80308 TCN 213
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
